A significant discovery in cancer investigation is emerging with the use of VHH fragments to reactivate dysfunctional p53. This essential cancer inhibitor protein is frequently disabled in many forms of tumors, leading https://social40.com/story7534842/mini-antibodies-restore-the-p53-protein-a-potential-pathway-for-tumor-treatment